53Biologics

Cell line transformation, banking and characterization (cGMP if required)

Others

53Biologics has proven experience producing a broad catalog of recombinant proteins (monoclonal, fusion, chimeric and fragment antibodies, biosimilars, enzymes, anticoagulants, vaccines, etc.) in a wide range of microbial expression systems such as bacter
3Clinical validation, 2Preclinical Validation, 1R+D